Financing through an issuance of stock acquisition rights with approximately 2.4 billion yen in funding. Alongside the acquisition and cancellation of the 21st stock acquisition rights, the 22nd stock acquisition rights are allocated to EVO FUND, with 750 million yen allocated to the redemption of the 15th unsecured bonds and the remaining 1.65 billion yen to growth investment in Beauty\/Wellness\/Financial sectors. Exercise price initially 103 yen, subsequently adjusted to 100% of closing price each adjustment date, with a lower limit of 52 yen. Exercise period from 2026-10-06 to 2028-10-06.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"price_fetched_at":"","company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"6731","jir_company_name":"Pixelia Co., Ltd.","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-09-17","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/09\/6731-20260917-01.pdf","jir_short_summary":"Financing through an issuance of stock acquisition rights with approximately 2.4 billion yen in funding. Alongside the acquisition and cancellation of the 21st stock acquisition rights, the 22nd stock acquisition rights are allocated to EVO FUND, with 750 million yen allocated to the redemption of the 15th unsecured bonds and the remaining 1.65 billion yen to growth investment in Beauty\/Wellness\/Financial sectors. Exercise price initially 103 yen, subsequently adjusted to 100% of closing price each adjustment date, with a lower limit of 52 yen. Exercise period from 2026-10-06 to 2028-10-06.","jir_summary":"### Overview of funding\nThis notice announces the resolution to issue and allocate the 22nd stock acquisition rights to EVO FUND through a third-party allotment. The total amount raised is 3,618,750 yen, and the number of potential shares is 24,125,000 shares. The funding is expected to be around 2.4 billion yen, with about 750 million yen allocated to the redemption of the 15th unsecured bonds, and the remaining approximately 1.65 billion yen allocated to growth investments and working capital in the Beauty\/Wellness\/Financial domains. The exercise price is initially 103 yen, and subsequently adjusted to 100% of the closing price on each adjustment date, with a lower limit of 52 yen. The exercise period is 2026\/10\/06 to 2028\/10\/06.\n\n### Background and strategy\nAgainst a backdrop of delays in the traditional financing plan and the challenge of balancing stable financial footing with growth investments, the plan is to streamline the capital structure through refinancing and to focus funds on the Beauty, Wellness, and Financial growth areas. In addition, by acquiring and cancelling the 21st stock acquisition rights, dilution will be managed, aiming to shift to a flexible and agile financing framework.","jir_financial_highlights":"Total paid-in amount: 3,618,750 yen (Unknown)\nPotential shares: 24,125,000 shares (Unknown)\nEstimated net funds raised: 2,476,464,750 yen (Unknown)\nRedemption amount of the 15th unsecured ordinary bonds: 750 million yen (As planned)","jir_category":"","jir_hashtags":"#Pixela, #CapitalPolicy, #StockAcquisitionRights, #Refinance","jir_key_figures":"Stock acquisition rights total: 3,000,000 units (potential shares: 30,000,000 shares)\nTotal amount of this stock acquisition rights issuance: 4,491,219,000 yen\nFunds raised: approximately 2,476 million yen","jir_meta_title":"\u3010Pixela\u3011 third-party allocation issued for the 22nd Stock Acquisition Rights | September 2026","jir_meta_description":"Pixela issues and allocates the 22nd stock acquisition rights through a third-party allotment to EVO FUND. Together with the acquisition and cancellation of the 21st rights, approximately 2.4 billion yen is raised. Use: redemption of the 15th bonds and growth investments\/working capital in Beauty\/Wellness\/Financial domains. Key points detailed.","jir_og_title":"\u3010Pixela\u3011 Issuance of Stock Acquisition Rights via Third-Party Allocation | September 2026","jir_og_description":"Pixela issues stock acquisition rights to finance funding. Details on redemption funding, growth investments, adjustment terms of the exercise price, and the rationality of issuance conditions.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":59882,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"share_buyback","footnotes":""},"sector":[],"importance":[],"class_list":["post-114908","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n